MedTrace Logo

Misoprostol Prior to Intrauterine Device (IUD) Insertion in Nulliparous Women

NCT00886834 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2014-12-22

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to see if inserting misoprostol in the vagina or between your cheek and gum before inserting an Intrauterine Device (IUD) in a woman who has never had a baby makes it easier and less painful.

Conditions

  • Contraception

Interventions

DRUG

Misoprostol

400 micrograms inserted vaginally or buccally, per the participants desire prior to the IUD insertion.

DRUG

Placebo

Pills which are identical to the study drug in appearance, taste, and smell.

Sponsors & Collaborators

Principal Investigators

  • David Turok, MD/MPH · University of Utah Department of Obstetrics and Gynecology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00886834 on ClinicalTrials.gov